Interestingly, expression of CDK19 and CDK20, which did not appear to influence cell survival in the in vitro conditions used to generate the DepMap dataset, are nonetheless associated with better/worse tumor progression free survival (PFS) in multiple tumor types (Fig. 1e, Supplementary Fig. 1). This evidence concerns the gene CDK19 and neoplasm.